- Home
- PPG vs BNTX Comparison
PPG vs BNTX Comparison
Compare PPG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPG | BNTX |
|---|---|---|
| Founded | 1883 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Paints/Coatings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 24.2B |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PPG | BNTX |
|---|---|---|
| Price | $104.45 | $100.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $124.25 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 1.8M | 800.8K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | ★ 46.11 | N/A |
| EPS | ★ 6.94 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.42 | N/A |
| Revenue Next Year | $3.03 | $3.37 |
| P/E Ratio | $15.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $93.39 | $79.81 |
| 52 Week High | $133.43 | $124.00 |
Technical Indicators
Market Signals| Indicator | PPG | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 52.71 |
| Support Level | $100.88 | $99.08 |
| Resistance Level | $106.10 | $113.05 |
| Average True Range (ATR) | 2.93 | 3.66 |
| MACD | -0.40 | 0.24 |
| Stochastic Oscillator | 3.13 | 41.11 |
Price Performance
Historical ComparisonAbout PPG PPG Industries Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.